Health Catalyst (NASDAQ: HCAT) insider to sell 13,836 restricted shares via MS

Rhea-AI Filing Summary

Health Catalyst, Inc. filed a Form 144 reporting 13,836 common shares to be sold through Morgan Stanley Smith Barney LLC on 03/02/2026, listed as restricted stock issued for compensation. The filing shows earlier dispositions by Linda Llewelyn of 9,762 shares on 12/01/2025 and 4,471 shares on 02/26/2026 with aggregate amounts of $28,311.75 and $7,814.41 respectively. Shares outstanding were reported as 70,730,884 as of 03/02/2026.

Insights

Governance Analyst

Form 144 notifies the market of an intended resale of restricted compensation shares by an insider.

The filing lists 13,836 common shares to be sold through Morgan Stanley Smith Barney LLC on 03/02/2026, described as restricted stock tied to compensation. Earlier reported dispositions by the same holder total 14,233 shares across 12/01/2025 and 02/26/2026, with aggregate proceeds shown in the excerpt.

Timing and execution specifics beyond the sale vehicle are not detailed in the excerpt; subsequent public filings or broker reports would show actual transaction timing and settlement.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC 1 New York Plaza, 38th Floor New York NY 10004	13836	22966.38	70730884	03/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/02/2026	Restricted Stock	Health Catalyst, Inc.			13836	03/02/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Linda Llewelyn c/o 10897 South River From Parkway #100 South Jordan UT 84095	Restricted Stock	12/01/2025	9762	28311.75
Linda Llewelyn c/o 10897 South River From Parkway #100 South Jordan UT 84095	Restricted Stock	02/26/2026	4471	7814.41

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Health Catalyst's Form 144 report about share sales?

It reports intent to sell 13,836 common shares via Morgan Stanley on 03/02/2026. The filing lists these as restricted stock issued for compensation and identifies prior dispositions by the same holder on 12/01/2025 and 02/26/2026.

Who is the selling party named in the HCAT Form 144?

The excerpt names Linda Llewelyn as a selling party linked to recent dispositions. The filing shows she sold 9,762 shares on 12/01/2025 and 4,471 shares on 02/26/2026, with aggregate amounts displayed in the excerpt.

How many shares outstanding does the filing show for HCAT?

The filing lists 70,730,884 shares outstanding as of 03/02/2026. This figure appears in the securities information section of the excerpt and provides a baseline share count on that date.

Are the shares in the Form 144 primary issuance or resale?

The excerpt identifies the transaction as a resale of restricted stock tied to compensation through a broker-dealer. It lists the shares as restricted stock and shows a broker (Morgan Stanley Smith Barney LLC) for the sale.

What aggregate proceeds are shown for the recent sales in the excerpt?

The excerpt displays proceeds of $28,311.75 for the 12/01/2025 disposition and $7,814.41 for the 02/26/2026 disposition. These figures appear alongside the respective share counts in the selling history.